Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905

被引:4
作者
Li, S [1 ]
Zhang, H [1 ]
Hoff, H [1 ]
Sell, C [1 ]
机构
[1] Allegheny Univ, MCP Hahnemann Sch Med, Dept Pathol & Lab Med, Gerontol Res Ctr, Philadelphia, PA 19129 USA
关键词
insulin-like growth factor 1; tyrosine kinase; cell proliferation; transformation;
D O I
10.1006/excr.1998.4167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have created a deletion mutant of the insulinlike growth factor type 1 receptor (IGF-1 R) which lacks the 36 amino acids (aa) immediately N-terminal to the transmembrane domain (Delta 870-905 IGF-1 R), This region has been reported to have a negative effect on the transforming potential of an avian sarcoma virus gag-IGF-l R fusion protein, We have sought to determine whether this region plays a similar role in the intact IGF-1 R. Analysis of the tyrosine kinase activity of the Delta 870-905 IGF-1 R shows that the mutant receptor is autophosphorylated without IGF-1 stimulation, indicating that the tyrosine kinase domain is constitutively active, In addition, processing of the receptor is decreased, resulting in accumulation of a high molecular weight proreceptor containing both a and beta-subunits. A well-characterized substrate of the IGF-1 R, IRS-1, is constitutively phosphorylated by the Delta 870-905 IGF-1 R and phosphoinositide (PI) 3-kinase activity, which is normally activated by the phosphorylation of IRS-1 following IGF-1 stimulation, is increased even in the absence of IGF-1. A second intracellular signal pathway normally activated by IGF-I, the MAP kinase pathway, showed no increase in activity in the absence of IGF-1. The Delta 870-905 IGF-1 R promoted cell proliferation only in the presence of IGF-1. We conclude that this deletion increases the basal activity of the IGF-1 receptor tyrosine kinase and activates PI 3-kinase, but is unable to stimulate MAP kinase in the absence of ligand, These results confirm those seen in the gag-IGF-l R fusion protein and indicate that aa 870-905 exert a negative effect on the tyrosine kinase domain of the beta-subunit of the IGF-1 R. (C) 1998 Academic Press.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [31] Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis
    Saldana, Sandra M.
    Lee, Heng-Huan
    Lowery, Frank J.
    Khotskaya, Yekaterina B.
    Xia, Weiya
    Zhang, Chenyu
    Chang, Shih-Shin
    Chou, Chao-Kai
    Steeg, Patricia S.
    Yu, Dihua
    Hung, Mien-Chie
    PLOS ONE, 2013, 8 (09):
  • [32] Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma
    Vishwamitra, Deeksha
    Shi, Ping
    Wilson, Desiree
    Manshouri, Roxsan
    Vega, Francisco
    Schlette, Ellen J.
    Amin, Hesham M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06): : 871 - 880
  • [33] Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues
    Topalak, Omer
    Kantar, Funda Ugur
    Ulukus, Cagnur
    Kupelioglu, Ali
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02) : 141 - 146
  • [34] HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene
    Aiello, Aurora
    Pandini, Giuseppe
    Sarfstein, Rive
    Werner, Haim
    Manfioletti, Guidalberto
    Vigneri, Riccardo
    Belfiore, Antonino
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1919 - 1926
  • [35] Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib
    Morgillo, Floriana
    Woo, Jong Kyu
    Kim, Edward S.
    Hong, Waun Ki
    Lee, Ho-Young
    CANCER RESEARCH, 2006, 66 (20) : 10100 - 10111
  • [36] Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia
    Zhang, Beiying
    Deng, Xiaoling
    You, Ruolan
    Liu, Jingru
    Hou, Diyu
    Wang, Xiaoting
    Chen, Shucheng
    Li, Dongliang
    Fu, Qiang
    Zhang, Jingdong
    Huang, Huifang
    Chen, Xiaoli
    NEOPLASIA, 2024, 47
  • [37] Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R)
    Zheng, Shao-wei
    Wan, Wen-guo
    Miao, Hai-xiong
    Tang, Rui
    Wang, Bin
    Huang, Qi-zhi
    Liu, Wei-le
    Zheng, Jian-ping
    Chen, Chu-qun
    Zhong, Hao-bo
    Li, Sheng-fa
    Sun, Chun-han
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4132 - 4140
  • [38] Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands
    Tian, Jie
    Lambertz, Isabel
    Berton, Thomas R.
    Rundhaug, Joyce E.
    Kiguchi, Kaoru
    Shirley, Stephanie H.
    DiGiovanni, John
    Conti, Claudio J.
    Fischer, Susan M.
    Fuchs-Young, Robin
    MOLECULAR CARCINOGENESIS, 2012, 51 (12) : 973 - 983
  • [39] Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy
    Wang, Li
    Yao, Min
    Zheng, Wenjie
    Fang, Miao
    Wu, Mengna
    Sun, Jianying
    Dong, Zhizhen
    Yao, Dengfu
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (04) : 272 - 280
  • [40] Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment
    Fagan, Dedra H.
    Uselman, Ryan R.
    Sachdev, Deepali
    Yee, Douglas
    CANCER RESEARCH, 2012, 72 (13) : 3372 - 3380